New Brunswick, NJ3 Active Studies

Ulcerative Colitis Clinical Trials in New Brunswick, NJ

Find 3 actively recruiting ulcerative colitis clinical trials in New Brunswick, NJ. Connect with local research sites and explore new treatment options.

3
Active Trials
2
Sponsors
78
Enrolling

Recruiting Ulcerative Colitis Studies in New Brunswick

About Ulcerative Colitis Clinical Trials in New Brunswick

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 3 ulcerative colitis clinical trials recruiting participants in New Brunswick, NJ. These studies are seeking a combined 78 participants. Research is being sponsored by Northwell Health, Rutgers, The State University of New Jersey. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in New Brunswick — FAQ

Are there ulcerative colitis clinical trials in New Brunswick?

Yes, there are 3 ulcerative colitis clinical trials currently recruiting in New Brunswick, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Brunswick?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you about next steps.

Are clinical trials in New Brunswick free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Brunswick studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 3 active trials in New Brunswick are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated July 19, 2026 from ClinicalTrials.gov